Exact Mass: 340.1858944
Exact Mass Matches: 340.1858944
Found 271 metabolites which its exact mass value is equals to given mass value 340.1858944
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pentamidine
C19H24N4O2 (340.18991639999996)
Pentamidine is only found in individuals that have used or taken this drug. It is an antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [PubChem]The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Mepenzolate
C21H26NO3+ (340.1912586000001)
Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
3-Hydroxyquinine
C20H24N2O3 (340.17868339999995)
3-Hydroxyquinine is a major metabolite of quinine. The formation of 3-hydroxyquinine is catalysed by cytochrome P450 3A4. [HMDB] 3-Hydroxyquinine is a major metabolite of quinine. The formation of 3-hydroxyquinine is catalysed by cytochrome P450 3A4.
Methantheline
C21H26NO3+ (340.1912586000001)
Methantheline is a synthetic antispasmodic. Antispasmodics are used to relieve cramps or spasms of the stomach, intestines, and bladder. Methantheline is used to treat intestine or stomach ulcers (peptic ulcer disease), intestine problems (irritable bowel syndrome), pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, or urinary problems (reflex neurogenic bladder in children). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
pentamidine
C19H24N4O2 (340.18991639999996)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent [Raw Data] CB201_Pentamidine_pos_50eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_40eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_30eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_20eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_10eV_isCID-10eV_rep000006.txt KEIO_ID P209; [MS2] KO009179 KEIO_ID P209; [MS3] KO009180 KEIO_ID P209
11-Hydroxytubotaiwine
C20H24N2O3 (340.17868339999995)
11-Hydroxytubotaiwine is an alkaloid from cultured cells of Aspidosperma quebracho-blanco (quebracho). Alkaloid from cultured cells of Aspidosperma quebracho-blanco (quebracho)
19,20-(E)-Vallesamine
C20H24N2O3 (340.17868339999995)
3-[2-(3-Guanidino-2-methyl-3-oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide
C19H24N4O2 (340.18991639999996)
3-hydroxyquinidine
C20H24N2O3 (340.17868339999995)
1-[3-(1,3-Benzodioxol-5-yloxy)propyl]-4-phenylpiperazine
C20H24N2O3 (340.17868339999995)
[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene
Glycyl-l-histidyl-l-lysine
2,4(1H,3H)-Pyrimidinedione, 1-(cyclopropylmethyl)-6-(3,5-dimethylbenzoyl)-5-(1-methylethyl)-
C20H24N2O3 (340.17868339999995)
Quinidine N-oxide
C20H24N2O3 (340.17868339999995)
undulifoline
C20H24N2O3 (340.17868339999995)
A natural product found in Alstonia spatulata.
yohimbinic acid
C20H24N2O3 (340.17868339999995)
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.445 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.442 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.437 Yohimbic acid is an amphoteric demethylated derivative of Yohimbine. Yohimbic acid exhibits vasodilatory action. Yohimbic acid also can be used for the research of osteoarthritis (OA)[1][2][3].
Poldine
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
17-Hydroxyyohimban-16-carboxylic acid
C20H24N2O3 (340.17868339999995)
17-O-Methyl-11-methoxy-Wieland-Gumlich-aldehyd
C20H24N2O3 (340.17868339999995)
21-O-methylleuconolam|leuconolam methyl ether|O-methylleuconolam
C20H24N2O3 (340.17868339999995)
Vallesamine
C20H24N2O3 (340.17868339999995)
19,20-(E)-Vallesamine is a natural product found in Tabernaemontana citrifolia, Alstonia rostrata, and Alstonia scholaris with data available.
alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone
1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose
4-(Hydroxy((1S)-5-vinylquinuclidin-2-yl)methyl)-6-methoxyquinolin-2(1H)-one
C20H24N2O3 (340.17868339999995)
11-dehydro-2,3-dinor Thromboxane B2
10-Hydroxy-16-epiaffinine
C20H24N2O3 (340.17868339999995)
1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester
5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate
18(19)-Hydroxy-19,20-dihydroakuammicine
C20H24N2O3 (340.17868339999995)
Yohimbic acid
C20H24N2O3 (340.17868339999995)
Yohimbic acid is a yohimban alkaloid. It is functionally related to a 17alpha-yohimbol. C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Yohimbic acid is an amphoteric demethylated derivative of Yohimbine. Yohimbic acid exhibits vasodilatory action. Yohimbic acid also can be used for the research of osteoarthritis (OA)[1][2][3].
Poldine
[C21H26NO3]+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate
Yohimbic acid
C20H24N2O3 (340.17868339999995)
Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Yohimbinoid alkaloids, Indole alkaloids Annotation level-1 Yohimbic acid is an amphoteric demethylated derivative of Yohimbine. Yohimbic acid exhibits vasodilatory action. Yohimbic acid also can be used for the research of osteoarthritis (OA)[1][2][3].
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]
methantheline
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
11-Hydroxytubotaiwine
C20H24N2O3 (340.17868339999995)
4-(QUINOLINE-3-CARBONYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C20H24N2O3 (340.17868339999995)
Copper Peptide
Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance[1][2][3].
1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE
1-[2-AMINO-1-(4-BENZYLOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
C20H24N2O3 (340.17868339999995)
2-(4-(BENZYLOXY)-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose
3-Fluorophenyl 4-trans-propylcyclohexylbenzoate
C22H25FO2 (340.18384819999994)
3-[2-hydroxy-3-(propan-2-ylamino)propoxy]-2-phenyl-3H-isoindol-1-one
C20H24N2O3 (340.17868339999995)
[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester
C19H24N4O2 (340.18991639999996)
(2S)-5-(tert-butyldiphenylsilyloxy)-1,2-epoxypentane
(2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate
C20H24N2O3 (340.17868339999995)
4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl
2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE
4,4-Methylenebis(1,1-dimethyl-3-phenylurea)
C19H24N4O2 (340.18991639999996)
Penthienate
C18H30NO3S+ (340.1946290000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-
[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene
1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine
C21H25FN2O (340.19508119999995)
Parapenzolate
C21H26NO3+ (340.1912586000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
17alpha-Hydroxyyohimban-16alpha-carboxylic acid
C20H24N2O3 (340.17868339999995)
(1S,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid
C20H24N2O3 (340.17868339999995)
2,5-Ethano-2H-azocino[4,3-b]indole-6-carboxylic acid, 4-ethylidene-1,3,4,5,6,7-hexahydro-6-(hydroxymethyl)-, methyl ester
C20H24N2O3 (340.17868339999995)
(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide
C19H24N4O2 (340.18991639999996)
[3-carboxy-2-[(3E,5E,8E)-9-carboxynona-3,5,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2E,5E,8E)-9-carboxynona-2,5,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3E,5E,7E)-9-carboxynona-3,5,7-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E,8E)-9-carboxynona-4,6,8-trienoyl]oxypropyl]-trimethylazanium
(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid
19,20-E-vallesamine
C20H24N2O3 (340.17868339999995)
A natural product found in Alstonia spatulata.
2-methoxy-3-methyl-N-[4-(4-morpholinylmethyl)phenyl]benzamide
C20H24N2O3 (340.17868339999995)
N-[2-(2,3-dimethylanilino)-2-oxoethyl]-3-(3-methylphenoxy)propanamide
C20H24N2O3 (340.17868339999995)
6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile
C19H24N4O2 (340.18991639999996)
(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one
C19H24N4O2 (340.18991639999996)
(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C20H24N2O3 (340.17868339999995)
(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C20H24N2O3 (340.17868339999995)
(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one
C19H24N4O2 (340.18991639999996)
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C20H24N2O3 (340.17868339999995)
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C20H24N2O3 (340.17868339999995)
(1S,15R,17S,18S)-17-ethyl-7-hydroxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylic acid
C20H24N2O3 (340.17868339999995)
mepenzolate
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Gly-His-Lys
A tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence.
1-[3-(1,3-benzodioxol-5-yloxy)propyl]-4-phenylpiperazine
C20H24N2O3 (340.17868339999995)
6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid
GAC0003A4
C20H24N2O3 (340.17868339999995)
GAC0003A4 is an LXR inverse agonist that inhibits LXR transcriptional activity. GAC0003A4 also efficiently degrades LXRβ protein. GAC0003A4 has the potential to be used in advanced pancreatic cancer and other refractory malignancies[1].
2'-(1-hydroxyethyl)-4'-methyl-9'-oxa-4'-azaspiro[indole-3,7'-tetracyclo[6.3.1.0²,⁶.0⁵,¹¹]dodecan]-2-ol
C20H24N2O3 (340.17868339999995)
2-[(1s,12s,13r,14r,15e)-13-(hydroxymethyl)-7-methoxy-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-15-ylidene]ethanol
C20H24N2O3 (340.17868339999995)
methyl (8s,13e,14s,16s,17r,18s)-13-ethylidene-8-hydroxy-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-triene-18-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (13e)-13-ethylidene-10-hydroxy-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C20H24N2O3 (340.17868339999995)
n-(1-hydroxy-3-phenylpropan-2-yl)-2-[(1-hydroxyethylidene)amino]-3-phenylpropanimidic acid
C20H24N2O3 (340.17868339999995)
(7'e)-7'-ethylidene-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H24N2O3 (340.17868339999995)
15-ethylidene-6-hydroxy-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-one
C20H24N2O3 (340.17868339999995)
12-ethyl-9-hydroxy-19-methoxy-8,16-diazatetracyclo[10.6.1.0²,⁷.0¹⁶,¹⁹]nonadeca-1(18),2,4,6,8-pentaen-17-one
C20H24N2O3 (340.17868339999995)
methyl (4as,5r)-5-(1h-indol-2-yl)-2-methyl-1h,3h,4h,4ah,6h,8h-oxepino[4,5-c]pyridine-5-carboxylate
C20H24N2O3 (340.17868339999995)
8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate
(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(1's,3s,4'r,7'z,8's,9'r)-7'-ethylidene-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H24N2O3 (340.17868339999995)
19,20-(e)-vallesamine
C20H24N2O3 (340.17868339999995)
{"Ingredient_id": "HBIN002156","Ingredient_name": "19,20-(e)-vallesamine","Alias": "19,20-(E)-vallesamine","Ingredient_formula": "C20H24N2O3","Ingredient_Smile": "CC=C1CN2CCC1C(C3=C(C2)C4=CC=CC=C4N3)(CO)C(=O)OC","Ingredient_weight": "340.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22311;41596","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "138113964","DrugBank_id": "NA"}
19-(r)-hydroxydihydrogelsemine
C20H24N2O3 (340.17868339999995)
{"Ingredient_id": "HBIN002214","Ingredient_name": "19-(r)-hydroxydihydrogelsemine","Alias": "NA","Ingredient_formula": "C20H24N2O3","Ingredient_Smile": "CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6NC4=O)C)O","Ingredient_weight": "340.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15832","TCMID_id": "9999","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101601182","DrugBank_id": "NA"}
19-(r)-hydroxydihydrokoymine
C20H24N2O3 (340.17868339999995)
{"Ingredient_id": "HBIN002217","Ingredient_name": "19-(r)-hydroxydihydrokoymine","Alias": "NA","Ingredient_formula": "C20H24N2O3","Ingredient_Smile": "CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6NC4=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31181","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6,7-seco-angustilobine B
C20H24N2O3 (340.17868339999995)
{"Ingredient_id": "HBIN012102","Ingredient_name": "6,7-seco-angustilobine B","Alias": "NA","Ingredient_formula": "C20H24N2O3","Ingredient_Smile": "CN1CCC2C(=CCOCC2(C3=CC4=CC=CC=C4N3)C(=O)OC)C1","Ingredient_weight": "340.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41099","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "13891912","DrugBank_id": "NA"}
16-ethyl-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium-9-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (2r,6s,7s,12r)-3-methyl-10-oxa-3,14-diazapentacyclo[11.7.0.0²,⁷.0⁶,¹².0¹⁵,²⁰]icosa-1(13),15,17,19-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
methyl 3-[(11r,11as)-11-ethyl-6-oxo-5h,8h,9h,10h,11ah-indolo[3,2-a]indolizin-11-yl]propanoate
C20H24N2O3 (340.17868339999995)
(2r,3r,12bs)-2-[(2z)-1-hydroxybut-2-en-2-yl]-3-(hydroxymethyl)-1h,2h,3h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-4-one
C20H24N2O3 (340.17868339999995)
(1's,3s,3'r,5's,8'r,9'r,11's)-3'-hydroxy-1,5'-dimethyl-6'-oxa-2'-azaspiro[indole-3,12'-tetracyclo[6.5.0.0²,¹¹.0⁴,⁹]tridecan]-2-one
C20H24N2O3 (340.17868339999995)
(2s,13s,15s,16r,17s,19s,20s,21r)-17-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-19-ol
C20H24N2O3 (340.17868339999995)
methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
methyl 18-(1-hydroxyethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
4-ethylidene-8-[2-(methoxyamino)phenyl]-13-oxa-6-azatetracyclo[6.5.0.0³,¹¹.0⁶,¹⁰]tridecan-7-one
C20H24N2O3 (340.17868339999995)
methyl 2-[(13z)-4a-ethyl-7-oxo-1h,2h,3h,4h,5h,6h-indolo[1,2-j]1,8-naphthyridin-13-ylidene]acetate
C20H24N2O3 (340.17868339999995)
methyl (12s,13s,14e)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.0³,¹¹.0⁴,⁹]heptadeca-3(11),4,6,8-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
(1r,10s,17s)-17-ethyl-10-hydroxy-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraen-14-one
C20H24N2O3 (340.17868339999995)
(1s,12s,14r,15s,18r)-14-ethyl-10-(methoxycarbonyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6,9-tetraen-15-ium-15-olate
C20H24N2O3 (340.17868339999995)
methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate
methyl (1s,11s,17r,18r)-18-ethyl-5-hydroxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate
3-[(5s,7r,9s)-9-hydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-11,13,15-trien-7-yl]-5h-furan-2-one
C20H24N2O3 (340.17868339999995)
(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate
methyl (2r,6s,7s,12s)-3-methyl-10-oxa-3,20-diazapentacyclo[11.7.0.0²,⁷.0⁶,¹².0¹⁴,¹⁹]icosa-1(13),14,16,18-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
methyl 3-methyl-10-oxa-3,20-diazapentacyclo[11.7.0.0²,⁷.0⁶,¹².0¹⁴,¹⁹]icosa-1(13),14,16,18-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (1r,11s,12r,17s)-12-[(1r)-1-hydroxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
(1'r,3s,4's,8'r,9's)-7'-ethylidene-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H24N2O3 (340.17868339999995)
(2z)-2-[(5s,7r,9s)-9,14-dihydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl]but-2-enal
C20H24N2O3 (340.17868339999995)
(2s)-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]-2-[(1-hydroxyethylidene)amino]-3-phenylpropanimidic acid
C20H24N2O3 (340.17868339999995)
18-ethyl-10-(methoxycarbonyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-14-olate
C20H24N2O3 (340.17868339999995)
(10r,15r,16r,17s)-15-[(1s)-1-hydroxyethyl]-13-methyl-19-oxa-3,13-diazahexacyclo[14.3.1.0²,¹⁰.0⁴,⁹.0¹⁰,¹⁵.0¹²,¹⁷]icosa-2,4,6,8-tetraen-13-ium-13-olate
C20H24N2O3 (340.17868339999995)
(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one
(2r,3s,12bs)-2-[(2e)-1-hydroxybut-2-en-2-yl]-3-(hydroxymethyl)-1h,2h,3h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-4-one
C20H24N2O3 (340.17868339999995)
(1'r,3s,4's,7'z,8'r,9's)-7'-ethylidene-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H24N2O3 (340.17868339999995)
methyl 2-[(4ar,13e,13ar)-4a-ethyl-7-oxo-1h,2h,3h,4h,5h,6h-indolo[1,2-j]1,8-naphthyridin-13-ylidene]acetate
C20H24N2O3 (340.17868339999995)
1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol
methyl (12r,13s,14z)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.0³,¹¹.0⁴,⁹]heptadeca-3(11),4,6,8-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(2s,13s,15s,16s,17r,19r,20s)-17-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-19-ol
C20H24N2O3 (340.17868339999995)
(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate
methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate
methyl 2-[(4ar,13z,13as)-4a-ethyl-7-oxo-1h,2h,3h,4h,5h,6h-indolo[1,2-j]1,8-naphthyridin-13-ylidene]acetate
C20H24N2O3 (340.17868339999995)
1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate
(1s,12s,14r,18r)-14-ethyl-10-(methoxycarbonyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6,9-tetraen-15-ium-15-olate
C20H24N2O3 (340.17868339999995)
7'-ethylidene-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H24N2O3 (340.17868339999995)
(2s,13s,16r,17r,19r,20s,21s)-19-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-17-ol
C20H24N2O3 (340.17868339999995)
methyl (11s,12s,17s)-12-[(1s)-1-hydroxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (1r,11s,12s,17s)-12-[(1s)-1-hydroxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (1s,11s,17r,18s)-18-[(1s)-1-hydroxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
(1r,3r,4z,8s,10s,11s)-8-(2-amino-4-methoxyphenyl)-4-ethylidene-13-oxa-6-azatetracyclo[6.5.0.0³,¹¹.0⁶,¹⁰]tridecan-7-one
C20H24N2O3 (340.17868339999995)
(1s,3s,4z,8r,10r,11r)-4-ethylidene-8-[2-(methoxyamino)phenyl]-13-oxa-6-azatetracyclo[6.5.0.0³,¹¹.0⁶,¹⁰]tridecan-7-one
C20H24N2O3 (340.17868339999995)
methyl (12r,13r,14e)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.0³,¹¹.0⁴,⁹]heptadeca-3(11),4,6,8-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(1's,3s,3's,6's,10'r)-9'-[(1s)-1-hydroxyethyl]-10'-(hydroxymethyl)-1-methyl-7'-azaspiro[indole-3,4'-tricyclo[4.3.1.0³,⁷]decan]-8'-en-2-one
C20H24N2O3 (340.17868339999995)
(1s,14r,15e,18r)-15-ethylidene-6-hydroxy-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-one
C20H24N2O3 (340.17868339999995)
(4s,12s,13r,14r,18r,20s)-8,14-dimethoxy-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9,16-tetraene
C20H24N2O3 (340.17868339999995)
8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate
(4z)-4-ethylidene-8-[2-(methoxyamino)phenyl]-13-oxa-6-azatetracyclo[6.5.0.0³,¹¹.0⁶,¹⁰]tridecan-7-one
C20H24N2O3 (340.17868339999995)
methyl 3-methyl-10-oxa-3,14-diazapentacyclo[11.7.0.0²,⁷.0⁶,¹².0¹⁵,²⁰]icosa-1(13),15,17,19-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(1r,9r,10s,12r,13r,16s)-16-[(1r)-1-hydroxyethyl]-8-methyl-15-oxa-8,18-diazahexacyclo[11.7.0.0¹,⁹.0²,⁷.0¹⁰,¹⁸.0¹²,¹⁶]icosa-2,4,6-trien-14-one
C20H24N2O3 (340.17868339999995)
8,14-dimethoxy-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9,16-tetraene
C20H24N2O3 (340.17868339999995)
methyl (1r,11s,12r,17s)-12-[(1s)-1-hydroxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate
(2s,13s,16r,17r,19r,20s,21s)-17-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-19-ol
C20H24N2O3 (340.17868339999995)
methyl (8r,13e,14s,16s,17r,18s)-13-ethylidene-8-hydroxy-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-triene-18-carboxylate
C20H24N2O3 (340.17868339999995)
methyl (3s,3ar,7as)-7a-ethenyl-3-(1h-indol-2-yl)-6-methyl-tetrahydro-2h-furo[2,3-c]pyridine-3-carboxylate
C20H24N2O3 (340.17868339999995)
(2r,3r,12bs)-2-[(2e)-1-hydroxybut-2-en-2-yl]-3-(hydroxymethyl)-1h,2h,3h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-4-one
C20H24N2O3 (340.17868339999995)
(2e)-2-{9,14-dihydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl}but-2-enal
C20H24N2O3 (340.17868339999995)
2-{9,14-dihydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl}but-2-enal
C20H24N2O3 (340.17868339999995)
(2e)-2-[(5s,7r,9s)-9,14-dihydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl]but-2-enal
C20H24N2O3 (340.17868339999995)
(2r,3s,12bs)-2-[(2z)-1-hydroxybut-2-en-2-yl]-3-(hydroxymethyl)-1h,2h,3h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-4-one
C20H24N2O3 (340.17868339999995)
(1r,2s,4s,5r)-5-ethenyl-2-[(r)-hydroxy(6-methoxyquinolin-4-yl)methyl]-1-azabicyclo[2.2.2]octan-1-ium-1-olate
C20H24N2O3 (340.17868339999995)
methyl (12s,13s,14z)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.0³,¹¹.0⁴,⁹]heptadeca-3(11),4,6,8-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(1'r,2'r,3s,5's,6's,8'r,11's)-2'-[(1r)-1-hydroxyethyl]-4'-methyl-9'-oxa-4'-azaspiro[indole-3,7'-tetracyclo[6.3.1.0²,⁶.0⁵,¹¹]dodecan]-2-ol
C20H24N2O3 (340.17868339999995)
methyl (14e)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.0³,¹¹.0⁴,⁹]heptadeca-3(11),4,6,8-tetraene-12-carboxylate
C20H24N2O3 (340.17868339999995)
(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate
methyl 2-[(4ar,13z)-4a-ethyl-7-oxo-1h,2h,3h,4h,5h,6h-indolo[1,2-j]1,8-naphthyridin-13-ylidene]acetate
C20H24N2O3 (340.17868339999995)
methyl (1r,9r,10s,12r,13e,18s)-13-ethylidene-10-hydroxy-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C20H24N2O3 (340.17868339999995)
(1s,3s,17s,21s)-6-methoxy-18-oxa-4,14-diazahexacyclo[9.9.2.0¹,¹⁷.0⁴,²².0⁵,¹⁰.0¹⁴,²¹]docosa-5,7,9,11(22)-tetraen-3-ol
C20H24N2O3 (340.17868339999995)
methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
16-(1-hydroxyethyl)-8-methyl-15-oxa-8,18-diazahexacyclo[11.7.0.0¹,⁹.0²,⁷.0¹⁰,¹⁸.0¹²,¹⁶]icosa-2,4,6-trien-14-one
C20H24N2O3 (340.17868339999995)
(2s,13s,15r,16r,17r,19r,20s,21s)-19-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-17-ol
C20H24N2O3 (340.17868339999995)
2-[13-(hydroxymethyl)-7-methoxy-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-15-ylidene]ethanol
C20H24N2O3 (340.17868339999995)
methyl 18-ethyl-5-hydroxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C20H24N2O3 (340.17868339999995)
(12r,19s)-12-ethyl-9-hydroxy-19-methoxy-8,16-diazatetracyclo[10.6.1.0²,⁷.0¹⁶,¹⁹]nonadeca-1(18),2,4,6,8-pentaen-17-one
C20H24N2O3 (340.17868339999995)
6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
methyl (1s,11s,12s,13z)-13-ethylidene-15-(2-hydroxyethyl)-10,15-diazatetracyclo[10.3.1.0²,¹⁰.0⁴,⁹]hexadeca-2,4,6,8-tetraene-11-carboxylate
C20H24N2O3 (340.17868339999995)
2-(1-hydroxybut-2-en-2-yl)-3-(hydroxymethyl)-1h,2h,3h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-4-one
C20H24N2O3 (340.17868339999995)
methyl 7a-ethenyl-3-(1h-indol-2-yl)-6-methyl-tetrahydro-2h-furo[2,3-c]pyridine-3-carboxylate
C20H24N2O3 (340.17868339999995)
7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl (2e,4e)-hexa-2,4-dienoate
(2s,13s,15r,16s,17r,19r,20s)-19-methoxy-21-methyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-17-ol
C20H24N2O3 (340.17868339999995)